Current Trials Addressing Early and Aggressive Secondary Prevention
Presenter:
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - AstraZenca; Bayer AG; Medtronic; Merck/Schering Plough
Video Player is loading.